These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3125288)

  • 1. The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.
    Grosset JH; Baohong J; Ito T
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):807-13. PubMed ID: 3125288
    [No Abstract]   [Full Text] [Related]  

  • 2. Committee 4: workshop on experimental chemotherapy of leprosy.
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary dapsone resistance in Bamako and Chingleput: final report; THELEP. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1987 Sep; 58(3):209-18. PubMed ID: 3312895
    [No Abstract]   [Full Text] [Related]  

  • 4. Six cases of dapsone-resistant tuberculoid leprosy.
    Pearson JM; Kiran KU; Stanley JN
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):534-5. PubMed ID: 6399070
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
    Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851
    [No Abstract]   [Full Text] [Related]  

  • 7. The chemotherapy of leprosy. Part 1.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
    [No Abstract]   [Full Text] [Related]  

  • 8. Dapsone-resistant leprosy-the THELEP approach.
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent trends in chemotherapy of leprosy.
    Parikh DA; Maniar JK; Parikh AC; Ganapati R
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
    Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
    Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in the study of the leprosy bacillus.
    Rees RJ
    Sci Basis Med Annu Rev; 1969; ():320-35. PubMed ID: 4917843
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H
    Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
    [No Abstract]   [Full Text] [Related]  

  • 13. The chemotherapy of leprosy from a microbiological standpoint.
    Pattyn SR
    Lepr India; 1977 Oct; 49(4):526-39. PubMed ID: 342826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP). Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):864-71. PubMed ID: 3325580
    [No Abstract]   [Full Text] [Related]  

  • 15. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
    Holmes IB; Hilson GR
    J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India).
    Bhatia VN; Balakrishnan S; Seshadri PS; Neelan PN; Roy RG
    Indian J Lepr; 1984; 56(3):587-94. PubMed ID: 6396340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.